179 related articles for article (PubMed ID: 3243317)
1. Percutaneous absorption of 14C-labelled 2-chlorobenzaldehyde in rats. Metabolism and toxicokinetics.
Rietveld EC; Hoet RM; Seutter-Berlage F; Van Rossum JM
Eur J Drug Metab Pharmacokinet; 1988; 13(4):231-40. PubMed ID: 3243317
[TBL] [Abstract][Full Text] [Related]
2. The fate of 2-chlorobenzylidene malononitrile (CS) in rats.
Brewster K; Harrison JM; Leadbeater L; Newman J; Upshall DG
Xenobiotica; 1987 Aug; 17(8):911-24. PubMed ID: 3118582
[TBL] [Abstract][Full Text] [Related]
3. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous toxicokinetic and repeated cutaneous contact studies with ethylene glycol monohexyl ether.
Ballantyne B; Jensen CB; Weaver EV
J Appl Toxicol; 2003; 23(5):301-14. PubMed ID: 12975769
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C]pyrrolidinone in the rat.
Midgley I; Hood AJ; Chasseaud LF; Brindley CJ; Baughman S; Allan G
Food Chem Toxicol; 1992 Jan; 30(1):57-64. PubMed ID: 1544607
[TBL] [Abstract][Full Text] [Related]
6. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
7. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
8. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
9. Preliminary studies on the absorption, distribution, metabolism, and excretion of THIP in animal and man using 14C-labelled compound.
Schultz B; Aaes-Jørgensen T; Bøgesø KP; Jørgensen A
Acta Pharmacol Toxicol (Copenh); 1981 Aug; 49(2):116-24. PubMed ID: 7336969
[TBL] [Abstract][Full Text] [Related]
10. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat.
Gerlóczy A; Fónagy A; Keresztes P; Perlaky L; Szejtli J
Arzneimittelforschung; 1985; 35(7):1042-7. PubMed ID: 4052138
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
13. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
14. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration].
Kellner HM; Arnold C; Christ OE; Eckert HG; Herok J; Hornke I; Rupp W
Arzneimittelforschung; 1981; 31(8A):1337-53. PubMed ID: 7197541
[TBL] [Abstract][Full Text] [Related]
16. Studies on benzyl acetate. III. The percutaneous absorption and disposition of [methylene-14C]benzyl acetate in the rat.
Chidgey MA; Kennedy JF; Caldwell J
Food Chem Toxicol; 1987 Jul; 25(7):521-5. PubMed ID: 3623341
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 2-ethyl-1,3-hexanediol. II. Nonsystemic disposition following single percutaneous or peroral doses in Fischer 344 rats.
Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Ballantyne B
Drug Metab Dispos; 1992; 20(1):6-18. PubMed ID: 1346998
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous absorption, biotransformation, retention and excretion of 1,3-diaminobenzene in the rat.
Lam HR; Bisgaard HC
Food Chem Toxicol; 1989 Nov; 27(11):741-9. PubMed ID: 2613120
[TBL] [Abstract][Full Text] [Related]
19. 2-14C-1-Allyl-3,5-diethyl-6-chlorouracil I: Synthesis, absorption in human skin, excretion, distribution, and metabolism in rats and rabbits.
Kaul R; Hempel B; Kiefer G
J Pharm Sci; 1982 Aug; 71(8):893-6. PubMed ID: 7120091
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics and biotransformation following topical use of the local corticoid prednicarbate].
Kellner HM; Eckert HG; Fehlhaber HW; Hornke I; Oekonomopulos R
Z Hautkr; 1986; 61 Suppl 1():18-40. PubMed ID: 3705671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
